Company / Cash per Share
OCULAR THERAPEUTIX, INC Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$4.67
FY2025
5-year range
$2.14 / $4.67
FY2021-FY2025
Trend
+37.0%
vs FY2024
Sector context
#43 of 205
Health Care
What the data says
OCULAR THERAPEUTIX, INC's cash per share of $4.67 is higher than 79% of companies in the Health Care sector (FY2025). Cash per Share has increased for 3 consecutive years, from $2.14 in FY2022 to $4.67 in FY2025.
Based on SEC 10-K filings.
4.67 in FY2025 with a 5-year CAGR of +34.0%. Top quartile in the Health Care sector.
Improved from $2.54 to $4.67 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +29.7%
- 5-Year CAGR
- +34.0%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 205This company $4.67 Sector average $67.98
▼
-93.1% below sector average
Key checks
Key Insights
- OCULAR THERAPEUTIX, INC's cash per share has grown for 3 consecutive years.
- In FY2025, cash per share increased 37.0% year-over-year.
- Ranks #43 out of 205 companies in the Health Care sector.
- Lowest cash per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.67 | +37.0% |
| FY2024 | $3.41 | +34.5% |
| FY2023 | $2.54 | +18.5% |
| FY2022 | $2.14 | -28.7% |
| FY2021 | $3.00 | +177.5% |
| FY2020 | $1.08 | -16.9% |
| FY2019 | $1.30 | -28.6% |
| FY2018 | $1.82 | +9.8% |
| FY2017 | $1.66 | +24.7% |
| FY2016 | $1.33 | +62.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026